hydrogen has been researched along with Encephalopathy, Hepatic in 8 studies
Hydrogen: The first chemical element in the periodic table with atomic symbol H, and atomic number 1. Protium (atomic weight 1) is by far the most common hydrogen isotope. Hydrogen also exists as the stable isotope DEUTERIUM (atomic weight 2) and the radioactive isotope TRITIUM (atomic weight 3). Hydrogen forms into a diatomic molecule at room temperature and appears as a highly flammable colorless and odorless gas.
dihydrogen : An elemental molecule consisting of two hydrogens joined by a single bond.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the metabolic changes in type C hepatic encephalopathy (CHE) rats after reducing manganese (Mn) intake." | 8.12 | Metabolic changes of the reduction of manganese intake in the hepatic encephalopathy rat: NMR- and MS-based metabolomics study. ( Li, Y; Lu, J; Qiang, J; Yang, X; Zhang, C, 2022) |
| "22 healthy controls and 52 patients with liver cirrhosis (16 with hepatic encephalopathy) were prospectively studied by means of lactulose or lactose hydrogen breath tests and lactose tolerance test." | 7.68 | [Lactulose fermentation and lactose absorption in Chilean patients with liver cirrhosis: importance for hepatic encephalopathy therapy]. ( Alegría, S; Antezana, C; Chesta, J, 1993) |
| "Overt hepatic encephalopathy (HE) is one of the complications of liver cirrhosis (LC), which negatively affects the prognosis and quality of life of patients." | 7.11 | Hydrogen-producing small intestinal bacterial overgrowth is associated with hepatic encephalopathy and liver function. ( Abe, H; Kamimura, K; Kawata, Y; Naruse, T; Sakamaki, A; Sato, C; Sato, H; Takahashi, K; Takamura, M; Terai, S; Tominaga, K; Tsuchiya, A; Yokoyama, J; Yokoyama, K, 2022) |
| "To investigate the metabolic changes in type C hepatic encephalopathy (CHE) rats after reducing manganese (Mn) intake." | 4.12 | Metabolic changes of the reduction of manganese intake in the hepatic encephalopathy rat: NMR- and MS-based metabolomics study. ( Li, Y; Lu, J; Qiang, J; Yang, X; Zhang, C, 2022) |
| "22 healthy controls and 52 patients with liver cirrhosis (16 with hepatic encephalopathy) were prospectively studied by means of lactulose or lactose hydrogen breath tests and lactose tolerance test." | 3.68 | [Lactulose fermentation and lactose absorption in Chilean patients with liver cirrhosis: importance for hepatic encephalopathy therapy]. ( Alegría, S; Antezana, C; Chesta, J, 1993) |
| "Overt hepatic encephalopathy (HE) is one of the complications of liver cirrhosis (LC), which negatively affects the prognosis and quality of life of patients." | 3.11 | Hydrogen-producing small intestinal bacterial overgrowth is associated with hepatic encephalopathy and liver function. ( Abe, H; Kamimura, K; Kawata, Y; Naruse, T; Sakamaki, A; Sato, C; Sato, H; Takahashi, K; Takamura, M; Terai, S; Tominaga, K; Tsuchiya, A; Yokoyama, J; Yokoyama, K, 2022) |
| "Human hepatic encephalopathy (HE) is identified by a new noninvasive test, proton magnetic resonance spectroscopy (1H MRS) applied to the brain in a few minutes." | 2.39 | Proton magnetic resonance spectroscopy: the new gold standard for diagnosis of clinical and subclinical hepatic encephalopathy? ( Blüml, S; Danielsen, ER; Ross, BD, 1996) |
| "This may result in Hepatic Encephalopathy (HE), a spectrum of neuro-psychiatric abnormalities which include changes in cognitive functions, consciousness, and behaviour." | 1.51 | An E-Nose for the Monitoring of Severe Liver Impairment: A Preliminary Study. ( Brunetto, M; Colantonio, S; D'Acunto, M; Germanese, D; Romagnoli, V; Salvati, A, 2019) |
| "In alcoholic patients with hepatic encephalopathy, there was no such correlation." | 1.33 | 1H-MR spectroscopy, magnetization transfer, and diffusion-weighted imaging in alcoholic and nonalcoholic patients with cirrhosis with hepatic encephalopathy. ( Cohnen, M; Häussinger, D; Hemker, J; Kircheis, G; Miese, F; Mödder, U; Wenserski, F; Wittsack, HJ, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yokoyama, K | 1 |
| Sakamaki, A | 1 |
| Takahashi, K | 1 |
| Naruse, T | 1 |
| Sato, C | 1 |
| Kawata, Y | 1 |
| Tominaga, K | 1 |
| Abe, H | 1 |
| Sato, H | 1 |
| Tsuchiya, A | 1 |
| Kamimura, K | 1 |
| Takamura, M | 1 |
| Yokoyama, J | 1 |
| Terai, S | 1 |
| Lu, J | 1 |
| Li, Y | 1 |
| Zhang, C | 1 |
| Yang, X | 1 |
| Qiang, J | 1 |
| Germanese, D | 1 |
| Colantonio, S | 1 |
| D'Acunto, M | 1 |
| Romagnoli, V | 1 |
| Salvati, A | 1 |
| Brunetto, M | 1 |
| Qu, J | 1 |
| Lü, X | 1 |
| Miese, F | 1 |
| Kircheis, G | 1 |
| Wittsack, HJ | 1 |
| Wenserski, F | 1 |
| Hemker, J | 1 |
| Mödder, U | 1 |
| Häussinger, D | 1 |
| Cohnen, M | 1 |
| Chesta, J | 1 |
| Antezana, C | 1 |
| Alegría, S | 1 |
| Ross, BD | 1 |
| Danielsen, ER | 1 |
| Blüml, S | 1 |
| Zweig, JI | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Role of Magnetic Resonance Imaging in Detection of Minimal Hepatic Encephalopathy[NCT04131205] | 40 participants (Anticipated) | Observational | 2019-06-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for hydrogen and Encephalopathy, Hepatic
| Article | Year |
|---|---|
Proton magnetic resonance spectroscopy: the new gold standard for diagnosis of clinical and subclinical hepatic encephalopathy?
Topics: Animals; Astrocytes; Brain; Choline; Cognition Disorders; Disease Models, Animal; Glutamine; Hepatic | 1996 |
Effects of lysine on ammonia formation, hydrogen ion, and potassium ion balance: a review and an hypothesis.
Topics: Acid-Base Equilibrium; Adolescent; Adult; Ammonia; Animals; Arginine; Biological Transport; Cystinur | 1973 |
1 trial available for hydrogen and Encephalopathy, Hepatic
| Article | Year |
|---|---|
Hydrogen-producing small intestinal bacterial overgrowth is associated with hepatic encephalopathy and liver function.
Topics: Adult; Aged; Aged, 80 and over; Breath Tests; Female; Gastrointestinal Microbiome; Hepatic Encephalo | 2022 |
5 other studies available for hydrogen and Encephalopathy, Hepatic
| Article | Year |
|---|---|
Metabolic changes of the reduction of manganese intake in the hepatic encephalopathy rat: NMR- and MS-based metabolomics study.
Topics: Amino Acids; Ammonia; Animals; gamma-Aminobutyric Acid; Glutamate-Ammonia Ligase; Hepatic Encephalop | 2022 |
An E-Nose for the Monitoring of Severe Liver Impairment: A Preliminary Study.
Topics: Breath Tests; Carbon Monoxide; Electronic Nose; Gases; Hepatic Encephalopathy; Humans; Hydrogen; Liv | 2019 |
Hydrogen: a promising novel treatment for hepatic encephalopathy?
Topics: Ammonia; Hepatic Encephalopathy; Humans; Hydrogen; Liver Diseases | 2013 |
1H-MR spectroscopy, magnetization transfer, and diffusion-weighted imaging in alcoholic and nonalcoholic patients with cirrhosis with hepatic encephalopathy.
Topics: Diffusion Magnetic Resonance Imaging; Female; Hepatic Encephalopathy; Humans; Hydrogen; Liver Cirrho | 2006 |
[Lactulose fermentation and lactose absorption in Chilean patients with liver cirrhosis: importance for hepatic encephalopathy therapy].
Topics: Adolescent; Adult; Aged; Case-Control Studies; Child; Chile; Female; Fermentation; Hepatic Encephalo | 1993 |